Retrospective Study
Copyright ©The Author(s) 2017.
World J Gastroenterol. Sep 14, 2017; 23(34): 6287-6293
Published online Sep 14, 2017. doi: 10.3748/wjg.v23.i34.6287
Table 2 Pancreatic cancer survival by usual adult body mass index category
Stage groupBMI categorynMedian overall survival, mo (95%CI)HR95%CIP valuePtrend value
Overall< 18.5988.0 (5.8-11.3)1.120.83-1.520.45
18.5-22.95889.7 (8.7-11.1)1.00Ref.Ref.
23-27.47919.5 (8.6-10.5)0.990.87-1.140.92
≥ 27.53069.8 (7.6-11.2)1.050.88-1.250.610.90
Resectable< 18.51511.1 (3.3-19.3)1.920.74-5.010.18
18.5-22.97315.6 (10.1-21.3)1.00Ref.Ref.
23-27.49316.7 (11.9-27.4)0.920.59-1.440.71
≥ 27.53616.2 (4.5-23.7)1.130.61-2.080.700.99
Unresectable locally advanced< 18.5177.0 (3.4-26.1)0.830.38-1.840.65
18.5-22.91088.7 (7.3-11.7)1.00Ref.Ref.
23-27.41438.6 (6.8-11.5)1.030.73-1.450.86
≥ 27.5488.6 (4.9-15.6)0.950.59-1.540.840.90
Metastatic< 18.5664.9 (2.8-8.0)1.070.76-1.510.70
18.5-22.94075.5 (4.0-6.4)1.00Ref.Ref.
23-27.45555.7 (3.7-6.8)0.990.84-1.160.89
≥ 27.52225.6 (3.3-7.7)1.020.84-1.270.760.88